retatrutide trade name Buy 20mg UK | High-Dose Reta Retatrutide vs Tirzepatide: Key Differences

However, the studies are focused mainly on individuals without diabetes

Exploring NHS pathways should be the first step

Send this story to a friend

M., & McAlister, F

However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)